On May 31, 2019, Jim Moutinho appeared on the Brad Davis Show The Talk of Connecticut 1360am to discuss responsible alcohol use and the family. Topics included alcohol use in society, evaluating what is problematic drinking versus responsible drinking, discussing topics with children and family, and upcoming family outings where alcohol is present.
go to www.talkofconnecticut.com to listen to the broadcast.
On April 26th, 2019 Jim Moutinho joined Paul Pacelli of the Talk of Connecticut 1360am to discuss the risk of increased use of Benzodiazepines in adolescents and adults. Topics include what they are, addiction potential and alternative treatment options. Go to www.talkofconnecticut.com or subcribe to the Talk of Connecticut Podcast for all the latest topics impacting Connecticut.
Apr 3, 2019
On March 29, 2019 Jim Moutinho, Founder/Director of Advanced Treatment Solutions stopped by the Talk of Connecticut WDRC 1360 and spoke to Brad Davis about the opiate crisis and best practices for treating individuals struggling with opiates. Topics include overdose, evaluations, Medication-Assisted Treatment options, and counseling. Click above for the entire interview.
Radio Interview on the Talk of Connecticut WDRC 1360 with Brad Davis
On Friday December 7th, 2018 Jim Moutinho was interviewed by Connecticut radio legend Brad Davis on the popular morning talk show "The Brad and Dan Show" on the Talk of Connecticut WDRC 1360.
Topics discussed during the interview include mental health and addiction issues facing CT, addiction and the brain, marijuana, counseling for mental health and best practices in addressing opioid crisis.
To hear the interview click here:
Or go to www.thetalkofconnecticut.com search for Jim Moutinho December 7th, 2018.
Dec 6, 2018
Our very own Jim Moutinho will be a special guest on the legendary Brad Davis Show on WDRC 1360am "The Talk of Connecticut" on December 7th at approximately 8:30am. Jim will be discussing mental health and addiction issues facing CT.
Go to www.talkofconnecticut.com for more details.